Publications by authors named "M Romanisio"
Female genital mutilation (FGM) is a form of gender-based violence (GBV) that may lead to adverse consequences on the physical and psychological health of survivors. Patients living with FGM have unique health needs, which have to be addressed from the perspective of human rights and sexual and reproductive health. The aim of this study was to understand the characteristics of the pool of users of two services targeting this population in Turin, given the significance this may have due to the high migratory flows from countries were FGM is performed.
View Article and Find Full Text PDFArticle Synopsis
- * Growth hormone deficiency (GHD) poses challenges due to varied diagnoses, daily treatment requirements, and lack of consistent biological markers, leading to a high potential for patient drop-out.
- * The review discusses GHD in transitioning patients, highlighting diagnostic difficulties, the importance of hormone replacement therapy, and the need for careful follow-up, especially in unique cases like cancer survivors.
Article Synopsis
- Pregnancy adds complexity to managing lipodystrophy disorders, which have been underreported in terms of related comorbidities and risks for women.
- A case study highlights a successful pregnancy in a 28-year-old woman with acquired partial lipodystrophy, showing improved glucose control but also leading to preterm delivery and maternal cardiac issues.
- Research indicates that while many women with various lipodystrophy phenotypes have successful pregnancies, they face high risks, necessitating intensive, multidisciplinary care and further investigation into leptin levels during pregnancy.
Purpose: Data regarding [18]FDG-PET/CT for the characterization of adrenal lesions are limited. Most of the studies proposed the tumor-to-liver maximum standardized uptake values (SUVratio) > 1.5 as the best cut off to predict malignancy.
View Article and Find Full Text PDFPurpose: The discrepancy between the biomarkers of disease's activity in acromegalic patients (GH and IGF-1) is almost frequent representing a challenge for the development of comorbidities in the long term. The aim of this study was to evaluate the prevalence and severity of metabolic comorbidities (diabetes, hypertension, and dyslipidemia) in surgically treated acromegalic patients with disease control and discordant GH and/or IGF-1 levels compared with those with concordant values.
Patients And Methods: Retrospective monocentric observational study on acromegalic surgically treated patients with biochemical remission (group A) or mild discordant GH or IGF-1 levels (group B).